Literature DB >> 20044583

Sudden death during adjuvant trastuzumab therapy of breast cancer.

M Oliveira1, M Nave2, N Gil2, J L Passos-Coelho3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 20044583     DOI： 10.1093/annonc/mdp587

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Cardiac complications associated with trastuzumab in the setting of adjuvant chemotherapy for breast cancer overexpressing human epidermal growth factor receptor type 2 - a prospective study.

Authors:  Grzegorz Piotrowski; Rafał Gawor; Arkadiusz Stasiak; Zenon Gawor; Piotr Potemski; Maciej Banach
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

2.  Trastuzumab-Induced Cardiomyopathy and Intermittent Left Bundle Branch Block.

Authors:  Hassan Tahir; Nikky Bardia; Kulwant Bath; Yasir Ahmed; Muhammad Rafique; Bassam Omar; Christopher Malozzi
Journal:  Cardiol Res       Date:  2019-07-31

3.  A case of ventricular fibrillation without left ventricular systolic dysfunction induced by trastuzumab emtansine for breast cancer.

Authors:  Morihiko Takeda; Tsuyoshi Takada; Nobuyuki Shiba
Journal:  J Cardiol Cases       Date:  2021-09-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.